The results from this trial indicate that early patching is more effective than EOT for the treatment of most children with amblyopia. Our findings also provide data for the personalisation of amblyopia treatments.

Amblyopia, a neural disorder induced by atypical visual experiences during the crucial period of visual development, affects 2–5% of the global population.1 Despite its prevalence, an optimal treatment protocol remains elusive. Issues, such as poor compliance, challenge the ability to attain an ideal outcome through patching, a primary treatment for amblyopia.2 These challenges have led to the fact that, in traditional strategies, patients with amblyopia usually undergo extended optical treatment (EOT) first to lessen the amount of subsequent patching for a better therapeutic experience.

Source: Biochimica et Biophysica Acta (BBA) - Reviews on Cancer